These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32857815)

  • 1. Whole genome sequencing analysis of high confidence variants of B-cell lymphoma in Canis familiaris.
    Sparks A; Woods JP; Bienzle D; Wood GA; Coomber BL
    PLoS One; 2020; 15(8):e0238183. PubMed ID: 32857815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA profiling in canine multicentric lymphoma.
    Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
    PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
    Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    J Vet Intern Med; 2011; 25(2):285-91. PubMed ID: 21314729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom.
    Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A
    Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocol.
    Wolf-Ringwall A; Lopez L; Elmslie R; Fowler B; Lori J; Sfiligoi G; Skope A; Arnold E; Hughes KL; Thamm DH; Ehrhart EJ; Avery AC; Lana SE
    Vet Comp Oncol; 2020 Sep; 18(3):342-352. PubMed ID: 31682319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
    Morgan E; O'Connell K; Thomson M; Griffin A
    Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma.
    Marquardt TM; Lindley SES; Smith AN; Cannon CM; Rodriguez CO; Thamm DH; Childress MO; Northrup NC
    J Am Vet Med Assoc; 2019 Jan; 254(2):236-242. PubMed ID: 30605381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
    Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Curran K; Thamm DH
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma.
    Al-Nadaf S; Rebhun RB; Curran KM; Venable RO; Skorupski KA; Willcox JL; Burton JH
    BMC Vet Res; 2018 Nov; 14(1):356. PubMed ID: 30458771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
    Itoh K; Ohtsu T; Fukuda H; Sasaki Y; Ogura M; Morishima Y; Chou T; Aikawa K; Uike N; Mizorogi F; Ohno T; Ikeda S; Sai T; Taniwaki M; Kawano F; Niimi M; Hotta T; Shimoyama M; Tobinai K;
    Ann Oncol; 2002 Sep; 13(9):1347-55. PubMed ID: 12196359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of hypermethylation of death-associated protein kinase (DAPK) gene CpG island in dogs with high-grade B-cell lymphoma.
    Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Ohno K; Tsujimoto H
    Vet Comp Oncol; 2018 Sep; 16(3):409-415. PubMed ID: 29527805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
    Lucas SR; Maranhão RC; Guerra JL; Coelho BM; Barboza R; Pozzi DH
    Vet Comp Oncol; 2015 Sep; 13(3):184-93. PubMed ID: 23615221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.